The short answer
Senna is a stimulant laxative that may add to potassium loss with indapamide. Ask about another constipation option; heart-rhythm concern is linked to low potassium and individual risk factors.
What this answer covers
Senna alexandrina: specified oral pod preparations in the inspected monograph. Leaf products and combinations require their own formulation review.
- Supplement or preparation
- Senna alexandrina
- Medication ingredient
- indapamide
The concern is potassium loss
Indapamide can lower potassium, and its prescribing information warns that stimulant laxatives add to that effect. The senna monograph also warns that combining with diuretics may enhance potassium loss. The concern is greater with prolonged misuse, excess dosing or diarrhea.
Heart-rhythm risk depends on the circumstances
Low potassium can make serious arrhythmias more likely, especially with an existing long QT interval, certain rhythm medicines or digoxin. This does not mean the herb has been shown to directly prolong QT with indapamide. Tell the clinician about heart conditions and all other medicines.
Ask about a suitable constipation plan
The indapamide SmPC advises using non-stimulant laxatives when a laxative is needed. Ask your pharmacist or prescriber which approach fits you, rather than adding repeated senna doses. The monograph describes short-term use; ongoing constipation or daily laxative need should be assessed.
Do not rely on taking doses apart
Spacing cannot be assumed to prevent potassium loss. Contact your care team for persistent diarrhea, weakness or muscle cramps, and seek urgent assessment for palpitations with faintness or collapse. Do not self-treat suspected low potassium with large supplement doses.
Evidence and practical considerations
Side effects & toxicity
Stimulant-laxative use with indapamide can add to potassium loss; resulting hypokalemia can increase arrhythmia risk, particularly in people already susceptible.
- Exact scope
- Senna alexandrina: specified oral pod preparations in the inspected monograph. Leaf products and combinations require their own formulation review. with Exact indapamide RxCUI 5764 IN, confirmed by current NLM properties. Oral indapamide dose and release formulation are retained; evidence for hydrochlorothiazide, other diuretics or combination antihypertensive products is not automatically equivalent.
- Medication form and route
- Oral
What remains uncertain
- Exact indapamide class warning and preparation-specific monograph support a conditional potassium-mediated risk. No direct exact-botanical QT prolongation or event rate established; prolonged misuse, diarrhea and other medicines modify risk.
Factors that may matter: Dose and duration; Exact supplement preparation; Kidney function; Other medicines; Baseline electrolyte status.
Read the supporting source summaries
Source 1: Current U.S. prescribing information
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients prescribed oral indapamide 1.25 or 2.5 mg tablets; additional dose-ranging study data.
Recommends periodic electrolyte and renal-function assessment. Potassium reductions were dose-related; some low measurements normalized without intervention. Calcium increases in indapamide studies were only slight. Includes a thiazide-like magnesium-loss warning.
How this applies: Exact medication guidance with explicit dose and nutrient distinctions. Exact indapamide RxCUI 5764 IN, confirmed by current NLM properties. Oral indapamide dose and release formulation are retained; evidence for hydrochlorothiazide, other diuretics or combination antihypertensive products is not automatically equivalent.
A label class warning is not proof that every patient has magnesium depletion or that routine supplements are required. Higher-dose risks and other diuretics cannot be assigned to every low-dose regimen.
Source 2: Current prescribing information
medicines.org.uk · Source check Sep 10, 2026
Population: Patients prescribed oral indapamide 2.5 mg.
Calcium salts may increase hypercalcemia risk through reduced urinary calcium elimination. Stimulant laxatives add to hypokalemia risk; non-stimulant laxatives are advised. Low potassium increases arrhythmia risk, particularly with long QT or digitalis, and may cause muscle injury. Low magnesium can make low potassium refractory.
How this applies: Exact indapamide guidance supports conditional calcium/laxative and electrolyte-management conclusions.
Regulatory guidance, not direct clinical trials for every botanical. Does not establish universal supplement requirements, a fixed supplement dose or protective spacing.
Source 3: Final regulatory herbal monograph
ema.europa.eu · Source check Sep 10, 2026
Population: Users of specified stimulant-laxative preparations.
Warns that long-term laxative abuse can cause hypokalemia and that diuretics can enhance potassium loss. Advises medical review with diuretics, antiarrhythmics or QT-prolonging medicines.
How this applies: Specific laxative preparation plus exact indapamide stimulant-laxative warning, with arrhythmia risk mediated by potassium loss.
No exact indapamide co-use trial or measured botanical-induced QT prolongation. Long-term misuse, diarrhea and dose matter; not every brief correctly used course has the same risk.
Source 4: Authoritative medication terminology
rxnav.nlm.nih.gov · Source check Sep 10, 2026
Population: Medication terminology.
Identifies indapamide as IN.
How this applies: Exact medication identifier.
Does not establish formulation equivalence or a clinical interaction.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Sources checked and article drafted. | |
| Research summary published |
Article revision: f9e3f4ce585b412f
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.